Pre-earnings options volume in Zevra Therapeutics (ZVRA) Inc is 2.4x normal with calls leading puts 3:1. Implied volatility suggests the market is anticipating a move near 12.4%, or $1.46, after results are released. Median move over the past eight quarters is 3.3%.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZVRA:
- ZVRA Earnings this Week: How Will it Perform?
- Zevra Therapeutics’ Strategic Advancements and Market Potential Drive Buy Rating
- Zevra Therapeutics: Buy Rating Affirmed on European Market Expansion and Growth Potential
- Zevra Therapeutics submits MAA to EMA for evaluation of arimoclomol
- Zevra Therapeutics announces MIPLYFFA , OLPRUVA presentations at SERGG